SYVEXIS Trademark

Trademark Overview


On Thursday, February 6, 2014, a trademark application was filed for SYVEXIS with the United States Patent and Trademark Office. The USPTO has given the SYVEXIS trademark a serial number of 79143871. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, February 6, 2024. This trademark is owned by NOVARTIS AG. The SYVEXIS trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
syvexis

General Information


Serial Number79143871
Word MarkSYVEXIS
Filing DateThursday, February 6, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, February 6, 2024
Registration Number4570533
Registration DateTuesday, July 22, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2014

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Thursday, March 13, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 14, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, March 25, 2014ASSIGNED TO EXAMINER
Wednesday, March 26, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 16, 2014NOTICE OF PUBLICATION
Wednesday, April 30, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, May 1, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 6, 2014PUBLISHED FOR OPPOSITION
Thursday, August 21, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, October 17, 2014NOTIFICATION PROCESSED BY IB
Friday, May 16, 2014NOTIFICATION PROCESSED BY IB
Tuesday, July 22, 2014REGISTERED-PRINCIPAL REGISTER
Monday, September 29, 2014FINAL DISPOSITION PROCESSED
Monday, September 29, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Sunday, April 24, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 26, 2021CANCELLED SECTION 71
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 11, 2022INVALIDATION PROCESSED
Friday, March 11, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, August 31, 2024DEATH OF INTERNATIONAL REGISTRATION

Related Keywords


syvexis human vaccines